Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 746092, 10 pages
http://dx.doi.org/10.1155/2015/746092
Research Article

Nucleofection of Rat Pheochromocytoma PC-12 Cells with Human Mutated Beta-Amyloid Precursor Protein Gene (APP-sw) Leads to Reduced Viability, Autophagy-Like Process, and Increased Expression and Secretion of Beta Amyloid

1Electron Microscopy Platform, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawińskiego 5, 02-106 Warsaw, Poland
2Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Nowoursynowska 159, 02-776 Warsaw, Poland

Received 18 July 2014; Accepted 6 October 2014

Academic Editor: Patrycja Pawlikowska

Copyright © 2015 Beata Pająk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Greene and A. S. Tischler, “Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 73, no. 7, pp. 2424–2428, 1976. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Alzheimer, “Uber eine eigenartige Erkrankung der Hirnrinde,” Allgemeine Zeitschrift fur Psychiatrie und phychish-Gerichtliche Medizin, vol. 64, pp. 146–148, 1907. View at Google Scholar
  3. D. Van Dam and P. P. De Deyn, “Drug discovery in dementia: the role of rodent models,” Nature Reviews Drug Discovery, vol. 5, no. 11, pp. 956–970, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. I. J. Martins, T. Berger, M. J. Sharman, G. Verdile, S. J. Fuller, and R. N. Martins, “Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease,” Journal of Neurochemistry, vol. 111, no. 6, pp. 1275–1308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. G. Ortiz, F. P. Pacheco-Moises, L. J. Flores-Alvarado et al., “Alzheimer disease and metabolism: role of cholesterol and membrane fluidity,” in Medicine, Mental and Behavioural Disorders and Diseases of the Nervous System, chapter 7, pp. 145–173, Intech, Rijeka, Croatia, 2013. View at Google Scholar
  6. I. A. Clark, L. M. Alleva, and B. Vissel, “The roles of TNF in brain dysfunction and disease,” Pharmacology and Therapeutics, vol. 128, no. 3, pp. 519–548, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Smith, A. Das, S. K. Ray, and N. L. Banik, “Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases,” Brain Research Bulletin, vol. 87, no. 1, pp. 10–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Mizushima, A. Yamamoto, M. Matsui, T. Yoshimori, and Y. Ohsumi, “In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker,” Molecular Biology of the Cell, vol. 15, no. 3, pp. 1101–1111, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. P. J. W. Naude, N. Dobos, D. van der Meer et al., “Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient mice,” Behavioural Brain Research, vol. 258, pp. 43–51, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. He, Z. Zhong, K. Lindholm et al., “Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice,” The Journal of Cell Biology, vol. 178, no. 5, pp. 829–841, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. D. M. Sama, H. M. Abdul, J. L. Furman et al., “Inhibition of soluble tumor necrosis factor ameliorates synaptic alterations and Ca2+ dysregulation in aged rats,” PLoS ONE, vol. 7, no. 5, Article ID e38170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. E. Jones and C. Jomary, “Clusterin,” International Journal of Biochemistry and Cell Biology, vol. 34, no. 5, pp. 427–431, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. I. P. Trougakos, M. Poulakou, M. Stathatos, A. Chalikia, A. Melidonis, and E. S. Gonos, “Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction,” Experimental Gerontology, vol. 37, no. 10-11, pp. 1175–1187, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. K. S. Leskov, S. Araki, J.-P. Lavik et al., “CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, bax-dependent pro-death factor,” The Journal of Biological Chemistry, vol. 286, no. 46, pp. 40083–40090, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. S. Leskov, D. Y. Klokov, J. Li, T. J. Kinsella, and D. A. Boothman, “Synthesis and functional analyses of nuclear clusterin, a cell death protein,” Journal of Biological Chemistry, vol. 278, no. 13, pp. 11590–11600, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. P. C. May and C. E. Finch, “Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration,” Trends in Neurosciences, vol. 15, no. 10, pp. 391–396, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Chiesa, N. Angeretti, E. Lucca et al., “Clusterin (SGP-2) induction in rat astroglial cells exposed to prion protein fragment 106–126,” European Journal of Neuroscience, vol. 8, no. 3, pp. 589–597, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. S.-W. Kang, S.-Y. Yoon, J.-Y. Park, and D.-H. Kim, “Unglycosylated clusterin variant accumulates in the endoplasmic reticulum and induces cytotoxicity,” International Journal of Biochemistry and Cell Biology, vol. 45, no. 2, pp. 221–231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Nixon, J. Wegiel, A. Kumar et al., “Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study,” Journal of Neuropathology & Experimental Neurology, vol. 64, no. 2, pp. 113–122, 2005. View at Google Scholar · View at Scopus
  20. R. A. Nixon, “The role of autophagy in neurodegenerative disease,” Nature Medicine, vol. 19, no. 8, pp. 983–997, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Kabeya, N. Mizushima, T. Ueno et al., “LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing,” The EMBO Journal, vol. 19, no. 21, pp. 5720–5728, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Suzuki, Y. Kubota, T. Sekito, and Y. Ohsumi, “Hierarchy of Atg proteins in pre-autophagosomal structure organization,” Genes to Cells, vol. 12, no. 2, pp. 209–218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. W. Johnson, T. J. Melia, and A. Yamamoto, “Modulating macroautophagy: a neuronal perspective,” Future Medicinal Chemistry, vol. 4, no. 13, pp. 1715–1731, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Ohsumi and N. Mizushima, “Two ubiquitin-like conjugation systems essential for autophagy,” Seminars in Cell & Developmental Biology, vol. 15, no. 2, pp. 231–236, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Kroemer, G. Mariño, and B. Levine, “Autophagy and the integrated stress response,” Molecular Cell, vol. 40, no. 2, pp. 280–293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Eckert, B. Steiner, C. Marques et al., “Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation,” Journal of Neuroscience Research, vol. 64, no. 2, pp. 183–192, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Keil, A. Bonert, C. A. Marques et al., “Amyloid β-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis,” The Journal of Biological Chemistry, vol. 279, no. 48, pp. 50310–50320, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. C. A. Marques, U. Keil, A. Bonert et al., “Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish APP mutation: oxidative stress, caspases and JNK pathway,” Journal of Biological Chemistry, vol. 278, no. 30, pp. 28294–28302, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Gozzelino, C. Sole, N. Llecha et al., “BCL-XL regulates TNF-α-mediated cell death independently of NF-κB, FLIP and IAPs,” Cell Research, vol. 18, no. 10, pp. 1020–1036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. D. Jacobson, J. F. Burne, and M. C. Raff, “Programmed cell death and Bcl-2 protection in the absence of a nucleus,” EMBO Journal, vol. 13, no. 8, pp. 1899–1910, 1994. View at Google Scholar · View at Scopus
  31. E. Borenfreund and J. A. Puerner, “A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90),” Journal of Tissue Culture Methods, vol. 9, no. 1, pp. 7–9, 1985. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Plantin-Carrenard, A. Bringuier, C. Derappe et al., “A fluorescence microplate assay using yopro-1 to measure apoptosis: application to HL60 cells subjected to oxidative stress,” Cell Biology and Toxicology, vol. 19, no. 2, pp. 121–133, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Eisenberg-Lerner and A. Kimchi, “The paradox of autophagy and its implication in cancer etiology and therapy,” Apoptosis, vol. 14, no. 4, pp. 376–391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A.-C. Johansson, H. Appelqvist, C. Nilsson, K. Kågedal, K. Roberg, and K. Öllinger, “Regulation of apoptosis-associated lysosomal membrane permeabilization,” Apoptosis, vol. 15, no. 5, pp. 527–540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Araki and K. Motojima, “Hydrophobic statins induce autophagy in cultured human rhabdomyosarcoma cells,” Biochemical and Biophysical Research Communications, vol. 367, no. 2, pp. 462–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Peng, W. Li, L. Yuan, R. G. Mehta, L. Kopelovich, and D. L. McCormick, “Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21,” PLoS ONE, vol. 8, no. 8, Article ID e70442, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Zhang, Z. Yang, L. Xie, L. Xu, D. Xu, and X. Liu, “Statins, autophagy and cancer metastasis,” The International Journal of Biochemistry & Cell Biology, vol. 45, no. 3, pp. 745–752, 2013. View at Publisher · View at Google Scholar · View at Scopus